Regulation and function of the rasGRP family of ras activators in blood cells

Genes and Cancer

Volumn 2, Issue 3, 2011, Pages 320-334

  Stone, James C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Diacylglycerol; Exchange factor; Immune receptor; Ras

Indexed keywords

B LYMPHOCYTE RECEPTOR; BRYOSTATIN 1; CALPHOSTIN C; DIACYLGLYCEROL; DIACYLGLYCEROL DERIVATIVE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RAP PROTEIN; RAS PROTEIN; T LYMPHOCYTE RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADAPTIVE IMMUNITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD CELL; CARCINOGENESIS; DRUG RESPONSE; DRUG TARGETING; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOCOMPETENT CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOMA; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE ADHESION; THYMOCYTE;

EID: 79960044081     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911408082     Document Type: Article

References (139)

1. Downward J, Graves JD, Warne PH, Rayter S, Cantrell DA. Stimulation of p21ras upon T-cell activation. Nature. 1990;346:719-23.
2. Izquierdo M, Downward J, Graves JD, Cantrell DA. Role of protein kinase C in T-cell antigen receptor regulation of p21ras: evidence that two p21ras regulatory pathways coexist in T cells. Mol Cell Biol. 1992;12:3305-12.
3. Egan SE, Weinberg RA. The pathway to signal achievement. Nature. 1993;365:781-3.
4. Fuller DM, Zhang W. Regulation of lymphocyte development and activation by the LAT family of adapter proteins. Immunol Rev. 2009;232:72-83.
5. Smith-Garvin JE, Burns JC, Gohil M, et al. T cell receptor signals direct the composition and function of the memory CD8+ T cell pool. Blood. 2010;116:5548-59.
6. Ebinu JO, Bottorff DA, Chan EY, Stang SL, Dunn RJ, Stone JC. RasGRP, a Ras guanyl nucleotidereleasing protein with calcium- and diacylglycerolbinding motifs. Science. 1998;280:1082-6.
7. Tognon CE, Kirk HE, Passmore LA, Whitehead IP, Der CJ, Kay RJ. Regulation of RasGRP viaa phorbol ester-responsive C1 domain. Mol Cell Biol. 1998;18:6995-7008.
8. Lorenzo PS, Beheshti M, Pettit GR, Stone JC, Blumberg PM. The guanine nucleotide exchange factor RasGRP is a high -affinity target for diacylglycerol and phorbol esters. Mol Pharmacol. 2000;57:840-6.
9. Ebinu JO, Stang SL, Teixeira C, et al. RasGRP links T-cell receptor signaling to Ras. Blood. 2000;95:3199-203.
10. Dower NA, Stang SL, Bottorff DA, et al. Ras- GRP is essential for mouse thymocyte differentiation and TCR signaling. Nat Immunol. 2000;1:317-21.
11. Alberola-Ila J, Hernandez-Hoyos G. The Ras/ MAPK cascade and the control of positive selection. Immunol Rev. 2003;191:79-96.
12. Swat W, Shinkai Y, Cheng HL, Davidson L, Alt FW. Activated Ras signals differentiation and expansion of CD4+8+ thymocytes. Proc Natl Acad Sci U S A. 1996;93:4683-7.
13. Norment AM, Bogatzki LY, Klinger M, Ojala EW, Bevan MJ, Kay RJ. Transgenic expression of RasGRP1 induces the maturation of doublenegative thymocytes and enhances the production of CD8 single-positive thymocytes. J Immunol. 2003;170:1141-9.
14. Priatel JJ, Teh SJ, Dower NA, Stone JC, Teh HS. RasGRP1 transduces low-grade TCR signals which are critical for T cell development, homeostasis, and differentiation. Immunity. 2002;17:617-27.
15. Priatel JJ, Chen X, Zenewicz LA, et al. Chronic immunodeficiency in mice lacking RasGRP1 results in CD4 T cell immune activation and exhaustion. J Immunol. 2007;179:2143-52.
16. Chen X, Priatel JJ, Chow MT, Teh HS. Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice. J Immunol. 2008;180:5973-82.
17. Priatel JJ, Chen X, Huang YH, et al. RasGRP1 regulates antigen-induced developmental programming by naive CD8 T cells. J Immunol. 2010;184:666-76.
18. Coughlin JJ, Stang SL, Dower NA, Stone JC. RasGRP1 and RasGRP3 regulate B cell proliferation by facilitating B cell receptor-Ras signaling. J Immunol. 2005;175:7179-84.
19. Layer K, Lin G, Nencioni A, et al. Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1. Immunity. 2003;19:243-55.
20. Tazmini G, Beaulieu N, Woo A, Zahedi B, Goulding RE, Kay RJ. Membrane localization of RasGRP1 is controlled by an EF-hand, and by the GEF domain. Biochim Biophys Acta. 2009;1793:447-61.
21. Gifford JL, Walsh MP, Vogel HJ. Structures and metal-ion-binding properties of the Ca2+-binding helix-loop-helix EF-hand motifs. Biochem J. 2007;405:199-221.
22. Roose JP, Mollenauer M, Gupta VA, Stone J, Weiss A. A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells. Mol Cell Biol. 2005;25:4426-41.
23. Zheng Y, Liu H, Coughlin J, Zheng J, Li L, Stone JC. Phosphorylation of RasGRP3 on threonine 133 provides a mechanistic link between PKC and Ras signaling systems in B cells. Blood. 2005;105:3648-54.
24. Roose JP, Mollenauer M, Ho M, Kurosaki T, Weiss A. Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes. Mol Cell Biol. 2007;27:2732-45.
25. Puente LG, Stone JC, Ostergaard HL. Evidence for protein kinase C-dependent and -independent activation of mitogen-activated protein kinase in T cells: potential role of additional diacylglycerol binding proteins. J Immunol. 2000;165:6865-71.
26. Teixeira C, Stang SL, Zheng Y, Beswick NS, Stone JC. Integration of DAG signaling systems mediated by PKC-dependent phosphorylation of RasGRP3. Blood. 2003;102:1414-20.
27. Morley SC, Weber KS, Kao H, Allen PM. Protein kinase C-theta is required for efficient positive selection. J Immunol. 2008;181:4696-708.
28. Goerge T, Ho-Tin-Noe B, Carbo C, et al. Inflammation induces hemorrhage in thrombocytopenia. Blood. 2008;111:4958-64.
29. Schneider H, Wang H, Raab M, et al. Adaptor SKAP-55 binds p21 activating exchange factor RasGRP1 and negatively regulates the p21-ERK pathway in T-cells. PLoS One. 2008;3:e1718.
30. Kosco KA, Cerignoli F, Williams S, Abraham RT, Mustelin T. SKAP55 modulates T cell antigen receptor-induced activation of the Ras-Erk-AP1 pathway by binding RasGRP1. Mol Immunol. 2008;45:510-22.
31. Fu G, Chen Y, Yu M, et al. Phospholipase C{gamma}1 is essential for T cell development, activation, and tolerance. J Exp Med. 2010;207:309-18.
32. Ehrhardt A, David MD, Ehrhardt GR, Schrader JW. Distinct mechanisms determine the patterns of differential activation of H-Ras, N-Ras, K-Ras 4B, and M-Ras by receptors for growth factors or antigen. Mol Cell Biol. 2004;24:6311-23.
33. Brindley DN, Pilquil C, Sariahmetoglu M, Reue K. Phosphatidate degradation: phosphatidate phosphatases (lipins) and lipid phosphate phosphatases. Biochim Biophys Acta. 2009;1791:956-61.
34. Mor A, Campi G, Du G, et al. The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane Ras via phospholipase D2. Nat Cell Biol. 2007;9:713-9.
35. Pettitt TR, Martin A, Horton T, Liossis C, Lord JM, Wakelam MJ. Diacylglycerol and phosphatidate generated by phospholipases C and D, respectively, have distinct fatty acid compositions and functions: phospholipase D-derived diacylglycerol does not activate protein kinase C in porcine aortic endothelial cells. J Biol Chem. 1997;272:17354-9.
36. Carrasco S, Merida I. Diacylglycerol, when simplicity becomes complex. Trends Biochem Sci. 2007;32:27-36.
37. Madani S, Hichami A, Cherkaoui-Malki M, Khan NA. Diacylglycerols containing Omega 3 and Omega 6 fatty acids bind to RasGRP and modulate MAP kinase activation. J Biol Chem. 2004;279:1176-83.
38. Chakraborty AK, Das J, Zikherman J, et al. Molecular origin and functional consequences of digital signaling and hysteresis during Ras activation in lymphocytes. Sci Signal. 2009;2:pt2.
39. Reynolds LF, de Bettignies C, Norton T, Beeser A, Chernoff J, Tybulewicz VL. Vav1 transduces T cell receptor signals to the activation of the Ras/ERK pathway via LAT, Sos, and RasGRP1. J Biol Chem. 2004;279:18239-46.
40. Zugaza JL, Caloca MJ, Bustelo XR. Inverted signaling hierarchy between RAS and RAC in T-lymphocytes. Oncogene. 2004;23:5823-33.
41. Caloca MJ, Zugaza JL, Matallanas D, Crespo P, Bustelo XR. Vav mediates Ras stimulation by direct activation of the GDP/GTP exchange factor Ras GRP1. EMBO J. 2003;22:3326-36.
42. Jones DR, Sanjuan MA, Stone JC, Merida I. Expression of a catalytically inactive form of diacylglycerol kinase alpha induces sustained signaling through RasGRP. FASEB J. 2002;16:595-7.
43. Sanjuan MA, Pradet-Balade B, Jones DR, et al. T cell activation in vivo targets diacylglycerol kinase alpha to the membrane: a novel mechanism for Ras attenuation. J Immunol. 2003;170:2877-83.
44. Zhong XP, Hainey EA, Olenchock BA, Zhao H, Topham MK, Koretzky GA. Regulation of T cell receptor-induced activation of the Ras-ERK pathway by diacylglycerol kinase zeta. J Biol Chem. 2002;277:31089-98.
45. Olenchock BA, Guo R, Carpenter JH, et al. Disruption of diacylglycerol metabolism impairs the induction of T cell anergy. Nat Immunol. 2006;7:1174-81.
46. Zha Y, Marks R, Ho AW, et al. T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-alpha. Nat Immunol. 2006;7:1166-73.
47. Macian F, Garcia-Cozar F, Im SH, Horton HF, Byrne MC, Rao A. Transcriptional mechanisms underlying lymphocyte tolerance. Cell. 2002;109:719-31.
48. Liu Y, Zhu M, Nishida K, Hirano T, Zhang W. An essential role for RasGRP1 in mast cell function and IgE-mediated allergic response. J Exp Med. 2007;204:93-103.
49. Downward J. Ras signalling and apoptosis. Curr Opin Genet Dev. 1998;8:49-54.
50. Poon HY, Stone JC. Functional links between diacylglycerol and phosphatidylinositol signaling systems in human leukocyte-derived cell lines. Biochem Biophys Res Commun. 2009;390: 1395-401.
51. Lee SH, Yun S, Lee J, et al. RasGRP1 is required for human NK cell function. J Immunol;2009, 183:7931-8.
52. de la Luz Sierra M, Sakakibara S, Gasperini P, et al. The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1. Blood. 2010;115:3970-9.
53. Kedra D, Seroussi E, Fransson I, et al. The germinal center kinase gene and a novel CDC25- like gene are located in the vicinity of the PYGM gene on 11q13. Hum Genet. 1997;100:611-9.
54. Kawasaki H, Springett GM, Toki S, et al. A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proc Natl Acad Sci U S A. 1998;95:13278-83.
55. Clyde-Smith J, Silins G, Gartside M, et al. Characterization of RasGRP2, a plasma membranetargeted, dual specificity Ras/Rap exchange factor. J Biol Chem. 2000;275:32260-7.
56. Irie K, Masuda A, Shindo M, Nakagawa Y, Ohigashi H. Tumor promoter binding of the protein kinase C C1 homology domain peptides of Ras- GRPs, chimaerins, and Unc13s. Bioorg Med Chem. 2004;12:4575-83.
57. Johnson JE, Goulding RE, Ding Z, et al. Differential membrane binding and diacylglycerol recognition by C1 domains of RasGRPs. Biochem J. 2007;406:223-36.
58. Pasvolsky R, Feigelson SW, Kilic SS, et al. A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets. J Exp Med. 2007;204:1571-82.
59. Malinin NL, Zhang L, Choi J, et al. A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med. 2009;15:313-8.
60. Manevich-Mendelson E, Feigelson SW, Pasvolsky R, et al. Loss of Kindlin-3 in LAD-III eliminates LFA-1 but not VLA-4 adhesiveness developed under shear flow conditions. Blood. 2009;114:2344-53.
61. Crittenden JR, Bergmeier W, Zhang Y, et al. CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med. 2004;10:982-6.
62. Stefanini L, Roden RC, Bergmeier W. CalDAGGEFI is at the nexus of calcium-dependent platelet activation. Blood. 2009;114:2506-14.
63. Boudreaux MK, Catalfamo JL, Klok M. Calcium-diacylglycerol guanine nucleotide exchange factor I gene mutations associated with loss of function in canine platelets. Transl Res. 2007;150:81-92.
64. Boudreaux MK, Schmutz SM, French PS. Calcium diacylglycerol guanine nucleotide exchange factor I (CalDAG-GEFI) gene mutations in a thrombopathic Simmental calf. Vet Pathol. 2007;44:932-5.
65. Eto K, Murphy R, Kerrigan SW, et al. Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling. Proc Natl Acad Sci U S A. 2002;99:12819-24.
66. Cifuni SM, Wagner DD, Bergmeier W. CalDAGGEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets. Blood. 2008;112:1696-703.
67. Carbo C, Duerschmied D, Goerge T, et al. Integrinindependent role of CalDAG-GEFI in neutrophil chemotaxis. J Leukoc Biol. 2010;88:313-9.
68. Caloca MJ, Zugaza JL, Vicente-Manzanares M, Sanchez-Madrid F, Bustelo XR. F-actindependent translocation of the Rap1 GDP/ GTP exchange factor RasGRP2. J Biol Chem. 2004;279:20435-46.
69. Suzuki K, Takahashi S, Haramoto Y, et al. XRASGRP2 is essential for blood vessel formation during Xenopus development. Int J Dev Biol. 2010;54:609-15.
70. Nagamine K, Matsuda A, Hori T. Identification of the gene regulatory region in human rasgrp2 gene in vascular endothelial cells. Biol Pharm Bull. 2010;33:1138-42.
71. Roberts DM, Anderson AL, Hidaka M, et al. A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters. Mol Cell Biol. 2004;24:10515-28.
72. Lorenzo PS, Kung JW, Bottorff DA, Garfield SH, Stone JC, Blumberg PM. Phorbol esters modulate the Ras exchange factor RasGRP3. Cancer Res. 2001;61:943-9.
73. Aiba Y, Oh-hora M, Kiyonaka S, et al. Activation of RasGRP3 by phosphorylation of Thr-133 is required for B cell receptor-mediated Ras activation. Proc Natl Acad Sci U S A. 2004;101:16612-7.
74. Brodie C, Steinhart R, Kazimirsky G, et al. PKCdelta associates with and is involved in the phosphorylation of RasGRP3 in response to phorbol esters. Mol Pharmacol. 2004;66:76-84.
75. Yamashita S, Mochizuki N, Ohba Y, et al. CalDAG-GEFIII activation of Ras, R-ras, and Rap1. J Biol Chem. 2000;275:25488-93.
76. Okamura SM, Oki-Idouchi CE, Lorenzo PS. The exchange factor and diacylglycerol receptor RasGRP3 interacts with dynein light chain 1 through its C-terminal domain. J Biol Chem. 2006;281:36132-9.
77. Coughlin JJ, Stang SL, Dower NA, Stone JC. The role of RasGRPs in regulation of lymphocyte proliferation. Immunol Lett. 2006;105:77-82.
78. Botelho RJ, Harrison RE, Stone JC, et al. Localized diacylglycerol-dependent stimulation of Ras and Rap1 during phagocytosis. J Biol Chem. 2009;284:28522-32.
79. Yang Y, Li L, Wong GW, et al. RasGRP4, a new mast cell-restricted Ras guanine nucleotidereleasing protein with calcium- and diacylglycerol- binding motifs: identification of defective variants of this signaling protein in asthma, mastocytosis, and mast cell leukemia patients and demonstration of the importance of RasGRP4 in mast cell development and function. J Biol Chem. 2002;277:25756-74.
80. Reuther GW, Lambert QT, Rebhun JF, Caligiuri MA, Quilliam LA, Der CJ. RasGRP4 is a novel Ras activator isolated from acute myeloid leukemia. J Biol Chem. 2002;277:30508-14.
81. Watanabe-Okochi N, Oki T, Komeno Y, et al. Possible involvement of RasGRP4 in leukemogenesis. Int J Hematol. 2009;89:470-81.
82. Li L, Yang Y, Wong GW, Stevens RL. Mast cells in airway hyporesponsive C3H/HeJ mice express a unique isoform of the signaling protein Ras guanine nucleotide releasing protein 4 that is unresponsive to diacylglycerol and phorbol esters. J Immunol. 2003;171:390-7.
83. Li L, Yang Y, Stevens RL. RasGRP4 regulates the expression of prostaglandin D2 in human and rat mast cell lines. J Biol Chem. 2003;278:4725-9.
84. Katsoulotos GP, Qi M, Qi JC, et al. The Diacylglycerol- dependent translocation of ras guanine nucleotide-releasing protein 4 inside a human mast cell line results in substantial phenotypic changes, including expression of interleukin 13 receptor alpha2. J Biol Chem. 2008;283:1610-21.
85. Altun-Gultekin Z, Andachi Y, Tsalik EL, Pilgrim D, Kohara Y, Hobert O. A regulatory cascade of three homeobox genes, ceh-10, ttx-3 and ceh- 3, controls cell fate specification of a defined interneuron class in C. elegans. Development. 2001;128:1951-69.
86. Esteban LM, Vicario-Abejon C, Fernandez- Salguero P, et al. Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol. 2001;21:1444-52.
87. Potenza N, Vecchione C, Notte A, et al. Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice. EMBO Rep. 2005;6:432-7.
88. Bivona TG, Perez De Castro I, Ahearn IM, et al. Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1. Nature. 2003;424:694-8.
89. Perez de Castro I, Bivona TG, Philips MR, Pellicer A. Ras activation in Jurkat T cells following low-grade stimulation of the T-cell receptor is specific to N-Ras and occurs only on the Golgi apparatus. Mol Cell Biol. 2004;24:3485-96.
90. Irvin BJ, Williams BL, Nilson AE, Maynor HO, Abraham RT. Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line. Mol Cell Biol. 2000;20:9149-61.
91. Daniels MA, Teixeiro E, Gill J, et al. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature. 2006;444:724-9.
92. Carrasco S, Merida I. Diacylglyceroldependent binding recruits PKCtheta and Ras- GRP1 C1 domains to specific subcellular localizations in living T lymphocytes. Mol Biol Cell. 2004;15:2932-42.
93. Shefler I, Mekori YA, Mor A. Stimulation of human mast cells by activated T cells leads to N-Ras activation through Ras guanine nucleotide releasing protein 1. J Allergy Clin Immunol. 2008;122:1222-5.
94. Rubio I, Grund S, Song SP, et al. TCR-induced activation of Ras proceeds at the plasma membrane and requires palmitoylation of N-Ras. J Immunol. 2010;185:3536-43.
95. Espagnolle N, Depoil D, Zaru R, et al. CD2 and TCR synergize for the activation of phospholipase Cgamma1/calcium pathway at the immunological synapse. Int Immunol. 2007;19:239-48.
96. Villalba M, Bi K, Hu J, et al. Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J Cell Biol. 2002;157:253-63.
97. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 1998;395:82-6.
98. Spitaler M., Emslie E., Wood C.D., Cantrell D. Diacylglycerol and protein kinase D localization during T lymphocyte activation. Immunity. 2006;24:535-46.
99. Merino E, Sanjuan MA, Moraga I, Cipres A, Merida I. Role of the diacylglycerol kinase alpha-conserved domains in membrane targeting in intact T cells. J Biol Chem. 2007;282: 35396-404.
100. Beaulieu N, Zahedi B, Goulding RE, et al. Regulation of RasGRP1 by B cell antigen receptor requires cooperativity between three domains controlling translocation to the plasma membrane. Mol Biol Cell. 2007;18:3156-68.
101. Leondaritis G, Petrikkos L, Mangoura D. Regulation of the Ras-GTPase activating protein neurofibromin by C-tail phosphorylation: implications for protein kinase C/Ras/extracellular signal-regulated kinase 1/2 pathway signaling and neuronal differentiation. J Neurochem. 2009;109:573-83.
102. Kim TJ, Cariappa A, Iacomini J, et al. Defective proliferative responses in B lymphocytes and thymocytes that lack neurofibromin. Mol Immunol. 2002;38:701-8.
103. Ingram DA, Zhang L, McCarthy J, et al. Lymphoproliferative defects in mice lacking the expression of neurofibromin: functional and biochemical consequences of Nf1 deficiency in T-cell development and function. Blood. 2002;100:3656-62.
104. Margarit SM, Sondermann H, Hall BE, et al. Structural evidence for feedback activation by Ras.GTP of the Ras-specific nucleotide exchange factor SOS. Cell. 2003;112:685-95.
105. Oh-hora M, Johmura S, Hashimoto A, Hikida M, Kurosaki T. Requirement for Ras guanine nucleotide releasing protein 3 in coupling phospholipase C-gamma2 to Ras in B cell receptor signaling. J Exp Med. 2003;198:1841-51.
106. Das J, Ho M, Zikherman J, et al. Digital signaling and hysteresis characterize ras activation in lymphoid cells. Cell. 2009;136:337-51.
107. Prasad A, Zikherman J, Das J, Roose JP, Weiss A, Chakraborty AK. Origin of the sharp boundary that discriminates positive and negative selection of thymocytes. Proc Natl Acad Sci U S A. 2009;106:528-33.
108. Houtman JC, Yamaguchi H, Barda-Saad M, et al. Oligomerization of signaling complexes by the multipoint binding of GRB2 to both LAT and SOS1. Nat Struct Mol Biol. 2006;13: 798-805.
109. Malhotra S, Kovats S, Zhang W, Coggeshall KM. Vav and Rac activation in B cell antigen receptor endocytosis involves Vav recruitment to the adapter protein LAB. J Biol Chem. 2009;284:36202-12.
110. Patrick MS, Oda H, Hayakawa K, et al. Gasp, a Grb2-associating protein, is critical for positive selection of thymocytes. Proc Natl Acad Sci U S A. 2009;106:16345-50.
111. Wang W, Fisher EM, Jia Q, et al. The Grb2 binding domain of mSos1 is not required for downstream signal transduction. Nat Genet. 1995;10:294-300.
112. Gureasko J, Galush WJ, Boykevisch S, et al. Membrane-dependent signal integration by the Ras activator Son of sevenless. Nat Struct Mol Biol. 2008;15:452-61.
113. Yadav KK, Bar-Sagi D. Allosteric gating of Son of sevenless activity by the histone domain. Proc Natl Acad Sci U S A. 2010;107:3436-40.
114. Ruiz S, Santos E, Bustelo XR. RasGRF2, a guanosine nucleotide exchange factor for Ras GTPases, participates in T-cell signaling responses. Mol Cell Biol. 2007;27:8127-42.
115. Gorelik G, Fang JY, Wu A, Sawalha AH, Richardson B. Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J Immunol. 2007;179:5553-63.
116. Yasuda S, Stevens RL, Terada T, et al. Defective expression of Ras guanyl nucleotidereleasing protein 1 in a subset of patients with systemic lupus erythematosus. J Immunol. 2007;179:4890-900.
117. Pan W, Zhu S, Yuan M, et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol. 2010;184:6773-81.
118. Deng YJ, Huang ZX, Zhou CJ, et al. Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus. Mol Immunol. 2006;43:1497-507.
119. Han JW, Zheng HF, Cui Y, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet. 2009;41:1234-7.
120. Qu HQ, Grant SF, Bradfield JP, et al. Association of RASGRP1 with type 1 diabetes is revealed by combined follow-up of two genome-wide studies. J Med Genet. 2009;46:553-4.
121. Mikkers H, Allen J, Knipscheer P, et al. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat Genet. 2002;32:153-9.
122. Kim R, Trubetskoy A, Suzuki T, Jenkins NA, Copeland NG, Lenz J. Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas. J Virol. 2003;77:2056-62.
123. Dupuy AJ, Morgan K, von Lintig FC, et al. Activation of the Rap1 guanine nucleotide exchange gene, CalDAG-GEF I, in BXH-2 murine myeloid leukemia. J Biol Chem. 2001;276:11804-11.
124. Suzuki T, Shen H, Akagi K, et al. New genes involved in cancer identified by retroviral tagging. Nat Genet. 2002;32:166-74.
125. Klinger MB, Guilbault B, Goulding RE, Kay RJ. Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors. Oncogene. 2005;24:2695-704.
126. Guo R, Wan CK, Carpenter JH, et al. Synergistic control of T cell development and tumor suppression by diacylglycerol kinase alpha and zeta. Proc Natl Acad Sci U S A. 2008;105:11909-14.
127. Lauchle JO, Kim D, Le DT, et al. Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras. Nature. 2009;461:411-4.
128. Raponi M, Lancet JE, Fan H, et al. A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia. Blood. 2008;111:2589-96.
129. Yang D, Kedei N, Li L, et al. RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype. Cancer Res. 2010;70:7905-17.
130. Pu Y, Perry NA, Yang D, et al. A novel diacylglycerol- lactone shows marked selectivity in vitro among C1 domains of protein kinase C (PKC) isoforms alpha and delta as well as selectivity for RasGRP compared with PKCalpha. J Biol Chem. 2005;280:27329-38.
131. Wender PA, Baryza JL, Bennett CE, et al. The practical synthesis of a novel and highly potent analogue of bryostatin. J Am Chem Soc. 2002;124:13648-9.
132. Hale KJ, Hummersone MG, Manaviazar S, Frigerio M. The chemistry and biology of the bryostatin antitumour macrolides. Nat Prod Rep. 2002;19:413-53.
133. Mutter R, Wills M. Chemistry and clinical biology of the bryostatins. Bioorg Med Chem. 2000;8:1841-60.
134. Stone JC, Stang SL, Zheng Y, et al. Synthetic bryostatin analogues activate the RasGRP1 signaling pathway. J Med Chem. 2004;47:6638- 4.
135. Stang SL, Lopez-Campistrous A, Song X, et al. A proapoptotic signaling pathway involving RasGRP, Erk, and Bim in B cells. Exp Hematol. 2009;37:122-34.
136. Gillings AS, Balmanno K, Wiggins CM, Johnson M, Cook SJ. Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics. FEBS J. 2009;276:6050-62.
137. Guilbault B, Kay RJ. RasGRP1 sensitizes an immature B cell line to antigen receptor-induced apoptosis. J Biol Chem. 2004;279:19523-30.
138. Han S, Knoepp SM, Hallman MA, Meier KE. RasGRP1 confers the phorbol ester-sensitive phenotype to EL4 lymphoma cells. Mol Pharmacol. 2007;71:314-22.
139. Wall NR, Mohammad RM, Al-Katib AM. Mitogen-activated protein kinase is required for bryostatin 1-induced differentiation of the human acute lymphoblastic leukemia cell line Reh. Cell Growth Differ. 2001;12:641-7.